Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks?

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is among the best get rich quick stocks to buy right now. On June 23, Kieran Ryan from Deutsche Bank started coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a Hold rating and a price target of $15.50. The firm highlighted the current transition to PayGo pharmacy, which it believes is a “transformational shift” to the company’s economic model. The stock appears fairly valued given the company’s “substantial” execution risk and complexity amid many shifts, the firm concluded.

Back on June 5, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced that it had received the CE mark for expanded indications for its automated insulin delivery systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems, leveraging Control-IQ+ AID technology, are approved for people living with type 1 diabetes during pregnancy and for adults with type 2 diabetes.

“These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” commented John Sheridan, president and chief executive officer. “By expanding access to our AID technology, we’re broadening our impact and advancing our mission to improve lives across the diabetes community.”

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

Syda Productions/Shutterstock.com

Overall, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has a Buy rating from more than half of the analysts covering the stock, with the remaining having a neutral stance. The company’s upside potential of 86.03% makes it one of the best get rich quick stocks to buy right now.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a California-based company specializing in technology solutions for diabetes patients. Incorporated in 2006, the company also provides single-use products.

While we acknowledge the risk and potential of TNDM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TNDM and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1